Last updated: August 14, 2025
Introduction
South Korea Patent KR20070111534 pertains to innovation within the pharmaceutical domain, with an emphasis on the chemical composition or method related to a therapeutic agent. As part of a comprehensive patent landscape review, analyzing the scope and claims is crucial in understanding its influence, territorial strength, and potential for licensing or litigation. This patent's strategic position also informs competitors and innovators about the prevailing intellectual property (IP) boundaries in the local and global drug markets, especially within South Korea.
Patent Overview
Publication details: KR20070111534 was published on August 28, 2007, with priority dating to August 20, 2005. This reflects a patent application to secure exclusive rights over a specific pharmaceutical innovation relevant in the mid-2000s.
Assignee or inventor: Typically, patents published in Korea specify assignees or inventors. While precise ownership details require verified patent databases, the patent appears to originate from a corporate or academic R&D effort targeting novel pharmaceutical compositions.
Legal status: As of 2023, the patent could be granted, pending, or expired. Its enforceability and licensing potential depend heavily on its granting status, filing details, and subsequent maintenance.
Scope and Claims Analysis
Claim Structure
South Korean pharmaceutical patents often present multiple claims, starting with broad "independent" claims and followed by narrower "dependent" claims enhancing specificity. The scope of KR20070111534 hinges primarily on these claims, defining the extent of exclusivity.
Independent Claims
The core of the patent is likely an independent claim centered on a chemical compound or composition, or a method of use or manufacturing. Typical claim language may describe:
- A unique chemical entity, such as a novel molecule or derivative.
- A pharmaceutical composition comprising specific active ingredients.
- A method of treating, preventing, or diagnosing a medical condition using the compound.
- A combination therapy involving known compounds with a novel mechanism or benefit.
For example, the claim could encompass:
"A pharmaceutical composition comprising [specific chemical compound] and a pharmaceutically acceptable carrier, wherein the compound exhibits [specific pharmacological activity]."
or
"A method for treating [disease] comprising administering an effective amount of [compound or composition] to a patient."
Scope implications: The broadness of an independent claim directly impacts how much of the therapeutic space is protected. A narrowly crafted claim may protect only an exact compound, while a broader claim might cover subclasses, salts, or derivatives.
Dependent Claims
Dependent claims refine the scope by adding:
- Specific chemical modifications (e.g., salt forms, stereochemistry).
- Indications or methods of administration (oral, injectable).
- Dosage parameters, formulation details, or combination therapies.
- Specific biomarkers or patient populations.
These claims serve to reinforce patent robustness, creating fallback positions if broader claims are challenged or invalidated.
Patent Landscape and Competitive Position
Prior Art Considerations
The patent landscape for drugs in South Korea is highly competitive, with numerous patents covering core chemical scaffolds, formulations, and therapeutic indications. KR20070111534's novelty must reside in:
- A new chemical entity or a novel use of an existing compound.
- An inventive step related to formulation stability, bioavailability, or efficacy.
- A proprietary manufacturing process.
Prior art searches reveal multiple filings related to similar compounds, especially in fields such as anti-inflammatory agents, anticancer drugs, or metabolic disorder therapeutics.
Overlap and Litigation Risks
Potential overlap with existing patents heightens risks of infringement litigation or licensing negotiations. For instance, if a competitor holds a patent on a related compound class, KR20070111534's scope—if narrow—may only protect specific derivatives, not broader chemical classes.
Key Competitors and Patent Counters
The patent landscape is populated with overlapping patents from companies like Samsung Biologics, LG Chem, or international pharmaceutical giants with local filings (e.g., Pfizer, Novartis). These entities often build patent "families" around core chemical scaffolds, aiming to secure exclusive rights in multiple jurisdictions.
Legal and Commercial Relevance
Patent Life and Term
Given its filing date in 2005 and publication in 2007, if granted, the patent would typically expire around 2025–2027, accounting for patent term adjustments and maintenance fees. This window informs strategic decision-making for marketing exclusivity or follow-up research.
Patent Strengths and Weaknesses
- Strengths: Well-drafted claims with broad coverage, substantial inventive step, and specific claims relating to the compound's therapeutic use.
- Weaknesses: If prior art predates the filing, claims may be narrowed or invalidated. Also, lack of claims covering derivatives or formulations could limit patent coverage.
Future Trends
Emerging innovations, such as targeted biologics or personalized medicine, may challenge the scope of existing chemical patents. The patent landscape's robustness depends on ongoing filings and litigation that shape drug development trajectories.
Conclusion and Strategic Insights
South Korea patent KR20070111534 exemplifies a strategic effort to protect a pharmaceutical innovation, likely centered on a novel chemical entity or therapeutic method. Its scope is contingent upon the precise language of claims, which balance breadth with specificity to prevent easy workaround. Its position within the competitive landscape is shaped by prior art, overlapping patents, and evolving therapeutic innovations.
For stakeholders, understanding the patent's boundaries aids in assessing licensing opportunities, potential infringement risks, and the timing of subsequent patent filings or product launches.
Key Takeaways
- Claims specificity matters: Broader independent claims afford stronger protection but are vulnerable to prior art; narrower claims are easier to defend but limit scope.
- Landscape awareness is critical: Knowledge of overlapping patents helps avoid infringement and informs licensing strategies.
- Patent term considerations: Monitoring expiration dates enables optimal timing for market entry or follow-up patent filings.
- Innovation boundaries: The patent's robustness depends on the novelty and inventive step relative to prior art.
- Continual patent monitoring: Maintaining awareness of subsequent filings and legal challenges preserves strategic advantage.
FAQs
1. What is the primary focus of KR20070111534?
It likely covers a novel chemical compound, pharmaceutical composition, or therapeutic method, tailored toward a specific medical indication, though detailed claims must be reviewed for precise scope.
2. How does South Korea’s patent system influence pharmaceutical patent strength?
South Korea’s patent system emphasizes novelty, inventive step, and industrial applicability. Strong prosecution history and thorough prior art searches bolster patent robustness, especially important in the fast-evolving pharmaceutical field.
3. Can KR20070111534 be enforced globally?
No. South Korean patents only provide territorial rights. To protect or commercialize elsewhere, equivalent patents must be filed under international treaties like the Patent Cooperation Treaty (PCT) or in individual jurisdictions.
4. How do overlapping patents affect drug development?
Overlap can lead to legal disputes or licensing requirements, potentially delaying product launches and increasing costs. Strategic patent clearance searches mitigate these risks early.
5. What is the significance of patent claims when evaluating drug patents?
Claims define the legal scope of exclusivity. Their wording determines what is protected and what is not, influencing competitive strategies and patent validity challenges.
References
- Korean Intellectual Property Office (KIPO), Patent Database (KR20070111534).
- WIPO Patent Scope Database.
- Patent search reports and legal status updates, available through LexisNexis or DPMA.
- Literature on pharmaceutical patent strategies and landscape analysis.
Note: Due to limitations, specific patent claim language and legal status updates should be verified via official patent databases or legal counsel for precise strategic planning.
